Beginning July 1, 2026, eligible Medicare beneficiaries can access four GLP-1 weight-loss medications through the temporary Medicare GLP-1 Bridge Program: Wegovy injections, Wegovy tablets, Zepbound KwikPen, and Foundayo
Resveratrol Resveratrol is a polyphenol marketed for its effects on metabolic health, antioxidant activity, and weight management
Platforms that integrate education and follow-up, such as those available through Healthcare.pro, allow clinicians to extend care beyond the visit without increasing workload
If you answered yes to any of these questions, dental implants may be the solution youve been seeking
Hepatic Impairment Patients with hepatic impairment have developed with cases of metformin-associated lactic acidosis